Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication
Event:
ESC Congress 2023
Topic:
Pharmacotherapy
Session:
Clinical heart failure from diagnostics to treatment
